RIGL short interest
Rigel Pharmaceuticals Inc. · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 2,855,433 |
|---|---|
| Change vs prior report | -336,378 (-10.5%) |
| Change over six months | -25.1% |
| Days to cover | 11.14 (sector: 3.78) |
| Average daily volume | 256,338 |
| Rank in Healthcare | #87 of 922 by days to cover |
RIGL short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 2,855,433 | -10.5% | 11.14 | 256,338 |
| 2026-09-15 | 3,191,811 | +0.3% | 15.83 | 201,576 |
| 2026-08-31 | 3,182,110 | -0.7% | 9.11 | 349,183 |
| 2026-08-14 | 3,203,364 | +3.6% | 9.76 | 328,254 |
| 2026-07-31 | 3,092,899 | -2.0% | 10.55 | 293,137 |
| 2026-07-15 | 3,157,453 | -2.9% | 7.87 | 401,367 |
| 2026-06-30 | 3,252,727 | -6.0% | 7.18 | 452,745 |
| 2026-06-15 | 3,458,879 | -12.1% | 11.18 | 309,283 |
| 2026-05-29 | 3,934,552 | -0.3% | 12.02 | 327,363 |
| 2026-05-15 | 3,945,787 | +0.3% | 7.49 | 526,989 |
| 2026-04-30 | 3,935,324 | -4.5% | 12.09 | 325,493 |
| 2026-04-15 | 4,121,844 | +8.2% | 11.26 | 365,938 |
| 2026-03-31 | 3,810,645 | +2.2% | 13.26 | 287,295 |
| 2026-03-13 | 3,729,897 | -0.6% | 7.06 | 528,099 |
| 2026-02-27 | 3,752,643 | -1.1% | 13.00 | 288,751 |
| 2026-02-13 | 3,793,344 | +1.7% | 14.25 | 266,185 |
| 2026-01-30 | 3,730,076 | +0.8% | 12.12 | 307,647 |
| 2026-01-15 | 3,701,312 | +7.6% | 6.72 | 550,620 |
| 2025-12-31 | 3,439,339 | +21.8% | 5.84 | 588,760 |
| 2025-12-15 | 2,824,418 | +2.4% | 5.20 | 543,071 |
| 2025-11-28 | 2,757,766 | -11.4% | 4.15 | 663,797 |
| 2025-11-14 | 3,111,107 | -9.4% | 3.47 | 897,347 |
| 2025-10-31 | 3,435,660 | -1.3% | 8.81 | 390,039 |
| 2025-10-15 | 3,480,017 | +24.9% | 6.46 | 538,612 |
| 2025-09-30 | 2,787,310 | +26.7% | 3.69 | 755,206 |
import finzdata as yf
yf.Ticker("RIGL").short_interest # every report since 2017
yf.Client().short_interest(["RIGL"], start="2018-01-01")Healthcare short interest · RIGL price history · Who owns RIGL · All short interest